How is the IN8bio Inc today?

The IN8bio Inc today is trading in the down by -5.04% at 2.26.

How has IN8bio Inc performed historically?

The IN8bio Inc is currently trading down -5.04% on an intraday basis in the past week the index fell -45.80%. The index has been up 927.27% in the past quarter and rose 107.34% in the past year. You can view this in the overview section.

What is IN8bio Inc Annual Net Profit?

IN8bio Inc Annual Net Profit fell 1.43% in the last year to $30.44 M. Its sector's average net profit growth for the last fiscal year was -13.89%.

What is IN8bio Inc Price to Earning Ratio?

IN8bio Inc Price to Earning Ratio is -0.28, which is negative.

What is IN8bio Inc Stock Price?

IN8bio Inc Stock Price rose 107.34% and outperformed its sector by 82.53% in the past year.

What is IN8bio Inc Quarterly Net profit?

IN8bio Inc Quarterly Net profit rose 35.18% YoY to $5.55 M. Its sector's average net profit growth YoY for the quarter was -238.55%.

What is IN8bio Inc Debt to Equity Ratio?

IN8bio Inc Debt to Equity Ratio of 0.35 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is IN8bio Inc Return on Equity(ROE)?

IN8bio Inc Return on Equity(ROE) for the last financial year was -154.44%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is IN8bio Inc Mutual Fund Holding?

IN8bio Inc Mutual Fund Holding decreased by 0.59% in the last quarter to 10.82.

What is IN8bio Inc Institutional Holding?

IN8bio Inc Institutional Holding decreased by 12.99% in the last quarter to 23.71.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
IN8BIO INC

IN8bio Inc XNAS: INAB

IN8bio Inc Live Share Price Today, Share Analysis and Chart

Name: IN8bio Inc: Is Infosys Ltd. worth buying?
Item: IN8bio Inc
Rating: 2.64791675
Author: Trendlyne DVM scores

about

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified ...

2.26 -0.12 (-5.04%)

45.80% Fall from 52W High

172.9K

XNAS Volume

XNAS 13 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

14.7 / 100

Technically Bullish

91.3 / 100

No estimates available

IN8bio Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

IN8bio Inc Live Share Price Today, Share Analysis and Chart

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified ...

45.80% Fall from 52W High

SWOT Analysis

IN8bio Inc Live Price Chart

IN8bio Inc FAQ

How is IN8bio Inc today?

IN8bio Inc today is trading in the red, and is down by -5.04% at 2.26.

How has IN8bio Inc performed historically?

IN8bio Inc is currently trading down -5.04% on an intraday basis. In the past week the stock fell -45.80%. stock has been up 927.27% in the past quarter and rose 107.34% in the past year. You can view this in the overview section.